drugset / Trial / NCT01199315

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses

NCT01199315

Phase 1 Completed 24 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to assess safety, tolerability and pharmacokinetics of AZD1446 in young and elderly healthy Japanese volunteers.

Timeline

Start
2010-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1446 Small molecule Oral

Indications

No indication recorded.